# Clinical Evaluation of Fenfuro (Fenugreek Seed Extract) in Type-2 Diabetic Subjects: an add-on Study

Study · id `cardio:ct-nct03066089` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03066089](<https://clinicaltrials.gov/study/NCT03066089>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03066089

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.

## Technical summary

Registry record NCT03066089. Non-randomized; no masking; primary purpose supportive care. Start 2015-12-14 (actual); primary completion 2017-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose supportive care
- Phase: Phase 4
- Enrolled: 104 participants (enrolled count; ClinicalTrials.gov record NCT03066089, source copy `cardio:ctgov-nct03066089-2018-01-31`, retrieved 2026-10-26)
- Started: 2015-12-14 (actual) (ClinicalTrials.gov record NCT03066089, source copy `cardio:ctgov-nct03066089-2018-01-31`, retrieved 2026-10-26)
- Primary completion: 2017-10 (actual) (ClinicalTrials.gov record NCT03066089, source copy `cardio:ctgov-nct03066089-2018-01-31`, retrieved 2026-10-26)
- Completion: 2017-10 (actual) (ClinicalTrials.gov record NCT03066089, source copy `cardio:ctgov-nct03066089-2018-01-31`, retrieved 2026-10-26)
- Countries: India (ClinicalTrials.gov record NCT03066089, source copy `cardio:ctgov-nct03066089-2018-01-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03066089-2018-01-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Evaluation of Fenfuro (Fenugreek Seed Extract) in Type-2 Diabetic Subjects: an add-on Study
- Condition: Type 2 Diabetes Mellitus
- Intervention (Drug): Fenfuro
- Lead sponsor: Chemical Resources
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: de03c7d34dbff1ccf9c22643f8f0f38e0c69d0003095ded4382c9f095470546d
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
